The novel therapy of the medication represents a major advance in the management of diabetes mellitus type 2. Distinct from existing medications, tirzepatide impacts two pathways – the GLP-1 hormone and GIP – https://tirzepatidepeptide797370.smblogsites.com/42105376/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment